Public
黑料正能量 Association content that is available to the public and all website users.
This week, Hacking Healthcare begins by examining some early conversations amongst policymakers on the topic of vaccine cards and passports, specifically drawing attention to the security and privacy concerns of such credentialing. Next, we check-in on the progress being made on a US-EU Privacy鈥
The U.S. Department of Health and Human Services鈥 (HHS) Health Sector Cybersecurity Coordination Center (HC3) invites you to join us this Thursday, at the first of our bi-monthly cybersecurity threat briefings in April. The topic will be "Ryuk Ransomware Variants".鈥 This initiative will provide鈥
In March 2021 the Federal Bureau of Investigation (FBI) and the Cybersecurity and Infrastructure Security Agency (CISA) observed Advanced Persistent Threat (APT) actors scanning devices on ports 4443, 8443, and 10443 for CVE-2018-13379, and enumerated devices for CVE-2020-12812 and CVE-2019-5591.鈥
The U.S. Department of Health and Human Services鈥 (HHS) Health Sector Cybersecurity Coordination Center (HC3) invites you to join us in one week, at the first of our bi-monthly cybersecurity threat briefings in April. The topic will be "Ryuk Ransomware Variants".
The National Counterintelligence and Security Center (NCSC) and its partners in government and industry today launched the 4th annual 鈥淣ational Supply Chain Integrity Month鈥 with a call to action for organizations across the country to strengthen their supply chains against foreign adversaries and鈥
Motion and Memorandum in Support of Motion to Intervene NOVO NORDISK v Cochran (March 2, 2021)
AHA shares initial recommendations for priorities to include in infrastructure legislative package.
The AHA and American Society of Health-System Pharmacists urge the Food and Drug Administration to take appropriate enforcement action to protect patients from a payer-mandated drug distribution model known as 鈥渨hite bagging.鈥
AHA urges the Department of Health and Human Services (HHS) to ensure hospitals currently participating in the 340B Drug Pricing Program continue to have access to the program despite changes in their payer mix as a result of the COVID-19 public health emergency (PHE).
Reply in Support of Motion to Intervene NOVO NORDISK v Cochran (March 29, 2021)